| 1 |
33439748 | Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin. | 2021 Mar 20 |
6 |
| 2 |
32064987 | Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels. | 2020 Jun |
1 |
| 3 |
28958290 | Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond. | 2017 Jul |
2 |
| 4 |
28983059 | Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes. | 2017 Dec |
1 |
| 5 |
26169489 | Where Does Lenalidomide Fit in Non-del(5q) MDS? | 2015 Sep |
1 |
| 6 |
22936658 | Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome. | 2012 Oct 25 |
2 |
| 7 |
21575928 | Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens. | 2011 Apr |
1 |
| 8 |
18713253 | Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma. | 2008 Oct |
1 |
| 9 |
17255789 | The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes. | 2007 Mar |
1 |
| 10 |
16735711 | Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q. | 2006 Jun 1 |
1 |
| 11 |
17076650 | Immunomodulatory drugs (IMiDs): a new treatment option for myelodysplastic syndromes. | 2006 Oct |
6 |
| 12 |
17242661 | Lenalidomide: targeted anemia therapy for myelodysplastic syndromes. | 2006 Dec |
1 |
| 13 |
17242663 | Cost effectiveness of lenalidomide in the treatment of transfusion-dependent myelodysplastic syndromes in the United States. | 2006 Dec |
1 |
| 14 |
15703420 | Efficacy of lenalidomide in myelodysplastic syndromes. | 2005 Feb 10 |
1 |
| 15 |
16085015 | Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS). | 2005 Aug |
1 |